Company intelligence / Profile preview

Qitone

Unknown

Ownership: Private
Development stage: Commercial

Overview

Qitone is a flavorless pro-ketone powder clinically proven to rapidly and sustainably boost blood ketone levels within 30 minutes. It supports brain function, metabolic health, endurance, cardiovascular function, and women’s hormonal balance. The product differentiates itself from other exogenous ketones by offering superior taste profile and sustained efficacy without digestive discomfort[1][2].

Therapeutic areas: Metabolic DisordersEndocrinologyOtherCardiovascularNeurologyWomen's Health
Modalities: Small moleculeNutritional supplement
Industry: Food & Nutrition

Drug pipeline

1 asset

Qitone

Commercial

Indications: Type 2 diabetes, Cognitive decline, Metabolic disorders

Partnerships

Buck Institute for Research on AgingSHEIS Research LaboratoryJuvenescence investment/affiliation

Beyond the preview

Go deeper on Qitone.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qitone.

Explore the full profile